Drug Landscape ›
BCG VACCINE ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 465
Most-reported reactions
Drug Ineffective — 89 reports (19.14%) Disseminated Bacillus Calmette-Guerin Infection — 80 reports (17.2%) Immune Reconstitution Inflammatory Syndrome — 68 reports (14.62%) Off Label Use — 49 reports (10.54%) Drug Intolerance — 39 reports (8.39%) Non-Hodgkin^S Lymphoma — 35 reports (7.53%) Pyrexia — 32 reports (6.88%) Arthralgia — 27 reports (5.81%) Rheumatoid Arthritis — 25 reports (5.38%) No Adverse Event — 21 reports (4.52%)
Source database →
BCG VACCINE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is BCG VACCINE approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for BCG VACCINE in United States?
Marketing authorisation holder not available in our data.